| 1.33 Delayed Data As of Sep 20 |  +0.15 / +12.71%Today’s Change | 1.03 Today|||52-Week Range 10.90 | -14.19% Year-to-Date |
| Previous close | 1.18 |
| Today’s open | 1.34 |
| Day’s range | 1.25 - 1.70 |
| Volume | 2,220,979 |
| Average volume (3 months) | 317,301 |
| Market cap | $260.0M |
| Earnings growth (last year) | +25.56% |
| Earnings growth (this year) | +76.35% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -97.72% |
| P/E ratio | NM |
| Price/Sales | 24.20 |
| Price/Book | 59.10 |
| Today’s change | Today’s % change | |
|---|---|---|
| CDXCChromadex Corp | -0.07 | -1.69% |
| LFVNLifeVantage Corp | +0.31 | +2.27% |
| CTSTCannTrust Holdings I... | -0.06 | -4.38% |
| NATRNatures Sunshine Pro... | -0.20 | -2.06% |
| Last reporting date | May 29, 2019 |
| EPS forecast (this quarter) | -$0.03 |
| Annual revenue (last year) | $198.7K |
| Annual profit (last year) | -$18.2M |
| Net profit margin | -6,958.39% |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director Craig Cook |
Chief Financial Officer & Director Stephen Anthony Stamp |
Corporate headquarters Cardiff, Cardiff |
